Difference between revisions of "Example orders for Cabazitaxel (Jevtana) in prostate cancer"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - ", 30 minutes prior" to " - 30 minutes prior") |
Warner-admin (talk | contribs) m (Text replacement - " " to " ") |
||
| (3 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
| − | <!--'''Use of this site is subject to you reading and agreeing with the terms set forth in the [[HemOnc.org_-_A_Hematology_Oncology_Wiki:General_disclaimer|disclaimer]]. If this is your first time visiting, we suggest you read the [[tutorial]].'''--> | + | <!--'''Use of this site is subject to you reading and agreeing with the terms set forth in the [[HemOnc.org_-_A_Hematology_Oncology_Wiki:General_disclaimer|disclaimer]]. If this is your first time visiting, we suggest you read the [[tutorial]].'''--> |
Remember that example order sets that may contain additional information about supportive medications, suggestions for monitoring, hydration, and pre-treatment screening information for chemotherapy regimens are purely anecdotal, provided only as examples of what some other providers may be using, and are typically not based on references in the primary literature. | Remember that example order sets that may contain additional information about supportive medications, suggestions for monitoring, hydration, and pre-treatment screening information for chemotherapy regimens are purely anecdotal, provided only as examples of what some other providers may be using, and are typically not based on references in the primary literature. | ||
| Line 14: | Line 14: | ||
'''21-day cycles''' | '''21-day cycles''' | ||
| − | ====Supportive | + | ====Supportive therapy==== |
| − | *[[Dexamethasone (Decadron)]] 12 mg PO once | + | *[[Dexamethasone (Decadron)]] 12 mg PO once; 30 minutes prior to chemotherapy |
| − | *Diphenhydramine (Benadryl) 25 to 50 mg IV once | + | *Diphenhydramine (Benadryl) 25 to 50 mg IV once; 30 minutes prior to chemotherapy |
| − | *Ondansetron (Zofran) 8 mg PO once | + | *Ondansetron (Zofran) 8 mg PO once; 30 minutes prior to chemotherapy |
*If ondansetron not used: Prochlorperazine (Compazine) 10 mg IV or PO once 30 to 60 minutes prior to chemotherapy | *If ondansetron not used: Prochlorperazine (Compazine) 10 mg IV or PO once 30 to 60 minutes prior to chemotherapy | ||
| − | *Famotidine (Pepcid) 20 mg IV over 15 minutes once | + | *Famotidine (Pepcid) 20 mg IV over 15 minutes once; 30 minutes prior to chemotherapy |
*[[Pegfilgrastim (Neulasta)]] 6 mg SC once on day 2, 24 hours after completion of chemotherapy | *[[Pegfilgrastim (Neulasta)]] 6 mg SC once on day 2, 24 hours after completion of chemotherapy | ||
| Line 27: | Line 27: | ||
Monitoring/precautions: | Monitoring/precautions: | ||
| − | *Notify physician if ANC | + | *Notify physician if ANC less than 1500, AST/ALT ≥1.5 times upper limit of normal |
*Exercise caution with/avoid use of Cyp3A inducers such as phenytoin and rifampin | *Exercise caution with/avoid use of Cyp3A inducers such as phenytoin and rifampin | ||
*Exercise caution with/avoid use for patients with hepatic insufficiency | *Exercise caution with/avoid use for patients with hepatic insufficiency | ||
Nursing: | Nursing: | ||
| − | *Patients without central lines: insert peripheral IV before therapy. | + | *Patients without central lines: insert peripheral IV before therapy. Flush peripheral IV with 10 mL 0.9% normal saline after each day's dose of chemotherapy. Remove peripheral IV when therapy is complete. |
| − | *Patients with central lines: access the central venous access device before therapy. | + | *Patients with central lines: access the central venous access device before therapy. Flush central line according to institutional guidelines after each day's dose of chemotherapy. Deaccess device when therapy is complete. |
===Example order set #2=== | ===Example order set #2=== | ||
| Line 40: | Line 40: | ||
'''21-day cycles''' | '''21-day cycles''' | ||
| − | ====Supportive | + | ====Supportive therapy==== |
| − | *[[Dexamethasone (Decadron)]] 12 mg IV once | + | *[[Dexamethasone (Decadron)]] 12 mg IV once; 30 minutes prior to chemotherapy |
*Prochlorperazine (Compazine) 10 mg IV or PO once 30 to 60 minutes prior to chemotherapy | *Prochlorperazine (Compazine) 10 mg IV or PO once 30 to 60 minutes prior to chemotherapy | ||
| − | *Diphenhydramine (Benadryl) 25 to 50 mg IV once | + | *Diphenhydramine (Benadryl) 25 to 50 mg IV once; 30 minutes prior to chemotherapy |
| − | *Famotidine (Pepcid) 20 mg IV over 15 minutes once | + | *Famotidine (Pepcid) 20 mg IV over 15 minutes once; 30 minutes prior to chemotherapy |
*Due to refractory nausea/vomiting, the following were also used: | *Due to refractory nausea/vomiting, the following were also used: | ||
| − | **Ondansetron (Zofran) 8 mg IV once | + | **Ondansetron (Zofran) 8 mg IV once; 30 minutes prior to chemotherapy |
| − | **Fosaprepitant (Emend) 150 mg IV once | + | **Fosaprepitant (Emend) 150 mg IV once; 30 minutes prior to chemotherapy, admix with dexamethasone and ondansetron |
Nursing: | Nursing: | ||
| − | *Patients without central lines: insert peripheral IV before therapy. | + | *Patients without central lines: insert peripheral IV before therapy. Flush peripheral IV with 10 mL 0.9% normal saline after each day's dose of chemotherapy. Remove peripheral IV when therapy is complete. |
| − | *Patients with central lines: access the central venous access device before therapy. | + | *Patients with central lines: access the central venous access device before therapy. Flush central line according to institutional guidelines after each day's dose of chemotherapy. Deaccess device when therapy is complete. |
[[Category:Example chemotherapy order sets]] | [[Category:Example chemotherapy order sets]] | ||
Latest revision as of 01:56, 1 June 2023
Remember that example order sets that may contain additional information about supportive medications, suggestions for monitoring, hydration, and pre-treatment screening information for chemotherapy regimens are purely anecdotal, provided only as examples of what some other providers may be using, and are typically not based on references in the primary literature.
Cabazitaxel (Jevtana)
Published regimens and references can be found on the prostate cancer page.
Example order set #1
- Cabazitaxel (Jevtana) 25 mg/m2 IV over 60 minutes once on day 1; use non-DEHP (paclitaxel) tubing
- Optional: Prednisone (Sterapred) 10 mg PO once per day on days 1 to 21
21-day cycles
Supportive therapy
- Dexamethasone (Decadron) 12 mg PO once; 30 minutes prior to chemotherapy
- Diphenhydramine (Benadryl) 25 to 50 mg IV once; 30 minutes prior to chemotherapy
- Ondansetron (Zofran) 8 mg PO once; 30 minutes prior to chemotherapy
- If ondansetron not used: Prochlorperazine (Compazine) 10 mg IV or PO once 30 to 60 minutes prior to chemotherapy
- Famotidine (Pepcid) 20 mg IV over 15 minutes once; 30 minutes prior to chemotherapy
- Pegfilgrastim (Neulasta) 6 mg SC once on day 2, 24 hours after completion of chemotherapy
Hydration:
- Normal saline IV continuous infusion at 5 mL/H
- Normal saline 25 to 50 mL IV prn flush before and after chemotherapy
Monitoring/precautions:
- Notify physician if ANC less than 1500, AST/ALT ≥1.5 times upper limit of normal
- Exercise caution with/avoid use of Cyp3A inducers such as phenytoin and rifampin
- Exercise caution with/avoid use for patients with hepatic insufficiency
Nursing:
- Patients without central lines: insert peripheral IV before therapy. Flush peripheral IV with 10 mL 0.9% normal saline after each day's dose of chemotherapy. Remove peripheral IV when therapy is complete.
- Patients with central lines: access the central venous access device before therapy. Flush central line according to institutional guidelines after each day's dose of chemotherapy. Deaccess device when therapy is complete.
Example order set #2
- Cabazitaxel (Jevtana) 25 mg/m2 IV over 60 minutes once on day 1; use non-DEHP (paclitaxel) tubing
21-day cycles
Supportive therapy
- Dexamethasone (Decadron) 12 mg IV once; 30 minutes prior to chemotherapy
- Prochlorperazine (Compazine) 10 mg IV or PO once 30 to 60 minutes prior to chemotherapy
- Diphenhydramine (Benadryl) 25 to 50 mg IV once; 30 minutes prior to chemotherapy
- Famotidine (Pepcid) 20 mg IV over 15 minutes once; 30 minutes prior to chemotherapy
- Due to refractory nausea/vomiting, the following were also used:
- Ondansetron (Zofran) 8 mg IV once; 30 minutes prior to chemotherapy
- Fosaprepitant (Emend) 150 mg IV once; 30 minutes prior to chemotherapy, admix with dexamethasone and ondansetron
Nursing:
- Patients without central lines: insert peripheral IV before therapy. Flush peripheral IV with 10 mL 0.9% normal saline after each day's dose of chemotherapy. Remove peripheral IV when therapy is complete.
- Patients with central lines: access the central venous access device before therapy. Flush central line according to institutional guidelines after each day's dose of chemotherapy. Deaccess device when therapy is complete.